"Albumin in heart surgery"? Effect of Starch in valve heart surgery "

Comparison of clinical effects of adding Albumin and Hydroxy ethyl Starch to prime solution in adult patients undergoing heart valve surgery

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20190512043568N1

Enrollment

Registered

2019-06-24

Start date

2018-08-31

Completion date

Unknown

Last updated

2019-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Assess the efect of Albumin and Starch on patients undergo heart valve surgery.

Interventions

Intervention 1: Intervention group:in this group added 50 cc Albumin to Oxygenator prime solution . Intervention 2: Control group:in this group added 500 cc Starch to oxygenator prime solution .

Eligibility

Sex/Gender

All

Age

17 Years to 70 Years

Inclusion criteria

Inclusion criteria: Adults undergo heart valve surgery by cardiopulmonary by pass

Exclusion criteria

Exclusion criteria: Cancer History of heart surgery Endocardit Platllet under 100000 unit Emergence operation Hemoglubin under 10 Ejectionfraction under 25% Aortic clamp time above 120 minutes and pump time above 150 minutes

Design outcomes

Primary

Measure	Time frame
Protrombin time ( Pt ). Timepoint: Pre operation , 24 and 48 hours post operation. Method of measurement: Labratory tests.;Amount use of Red Blood cells. Timepoint: Before and after the operation daily. Method of measurement: Laboratory tests.;Amount of used platelets. Timepoint: Before and after the operation daily. Method of measurement: Laboratory tests.;Creatinine. Timepoint: Pre operation, 24 and 48 hours post operation. Method of measurement: Laboratory tests.;Intensive care unit stay. Timepoint: Entrance time to intensive care unit until discharge intensive care unit. Method of measurement: Intensive care unit stay (day).	—

Measure

Time frame

Protrombin time ( Pt ). Timepoint: Pre operation , 24 and 48 hours post operation. Method of measurement: Labratory tests.;Amount use of Red Blood cells. Timepoint: Before and after the operation daily. Method of measurement: Laboratory tests.;Amount of used platelets. Timepoint: Before and after the operation daily. Method of measurement: Laboratory tests.;Creatinine. Timepoint: Pre operation, 24 and 48 hours post operation. Method of measurement: Laboratory tests.;Intensive care unit stay. Timepoint: Entrance time to intensive care unit until discharge intensive care unit. Method of measurement: Intensive care unit stay (day).

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactEgbal Ahadmohebi

Rajaei heart center

egbalmohebi@yahoo.com+98 21 2204 2026

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026